Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy
about
Exosomes as a tumor immune escape mechanism: possible therapeutic implicationsThe strength of the T cell response against a surrogate tumor antigen induced by oncolytic VSV therapy does not correlate with tumor controlFRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapyTumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.Induction of antitumor immunity through xenoplacental immunization.Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patientsProspective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial.Immunotherapy for melanoma: current status and perspectives.Oncolytic viruses: a novel form of immunotherapy.Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.Advancing Cancer Therapy with Present and Emerging Immuno-Oncology ApproachesUnderstanding dendritic cell immunotherapy in ovarian cancer.Viral inhibitors of NKG2D ligands for tumor surveillance.Tuberculosis, smoking and risk for lung cancer incidence and mortality.A study on assessment of mast cells in oral squamous cell carcinoma.Evaluation of humoral immunity in oral cancer patients from a nigerian referral centre.Application of Various Types of Liposomes in Drug Delivery Systems.The nuclear factor-kappa B pathway and response to treatment in breast cancer.Improvement of Antitumor Therapies Based on Vaccines and Immune-Checkpoint Inhibitors by Counteracting Tumor-Immunostimulation.Current Strategies to Enhance Anti-Tumour Immunity.PhysiCell: An open source physics-based cell simulator for 3-D multicellular systems.Marker profiling of normal keratinocytes identifies the stroma from squamous cell carcinoma of the oral cavity as a modulatory microenvironment in co-culture
P2860
Q21245472-7927A205-F3CF-4EEA-9514-4342D1D4EF33Q33724224-7E47B069-C486-45D5-8B0D-58E40FB715C0Q33951651-09DA1427-2930-4402-9ADD-852FB3011877Q34097414-8D8C53A4-A0E4-46F3-B5FE-E870CF72E102Q34695812-AE4666DC-0A66-47B4-9360-F4D27F3E0E70Q35021619-2EFD938A-8502-4995-907C-365D3914DE78Q35060987-A9F81D70-523C-4966-9C26-F91658988891Q36453216-E76720D7-7638-406E-8F13-F8C479401623Q37300008-A3B244D5-89D4-4B45-9A16-B2E7F9BF5637Q37635491-CEBA9D34-8BB4-4F1E-BDD9-A8F3A557312DQ38689153-60A9ED37-6331-4DA1-8515-2B91B9E3B44BQ38808249-779100B8-32FF-4FDC-8793-F11F41A37441Q38870478-612138A7-A070-44BB-8A36-519EA83E99C4Q40623451-342B938B-CF2B-43D8-988A-72049C3BF6E1Q41232099-8F94A678-88D6-47B1-ABE4-29BB28BE9085Q41894093-EFF0240E-1171-4636-AA83-085E2592C56FQ42352352-EF66D501-C7B8-47CD-86FD-665CAA0D5A68Q47813995-8B094A39-6378-43BC-8C62-72DC1DC5B43BQ49872011-12E64BBE-B861-4750-ABC1-144259B4E3C7Q52344613-0C1AB52A-4F45-414D-AC65-FE265004BD8DQ52688323-92712D2D-6950-4387-82B4-8B457D126296Q57664423-4A13DEE5-F8CD-4F9E-9490-7D0E8F6E08FC
P2860
Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Revisiting immunosurveillance ...... tions for cancer immunotherapy
@ast
Revisiting immunosurveillance ...... tions for cancer immunotherapy
@en
Revisiting immunosurveillance ...... tions for cancer immunotherapy
@nl
type
label
Revisiting immunosurveillance ...... tions for cancer immunotherapy
@ast
Revisiting immunosurveillance ...... tions for cancer immunotherapy
@en
Revisiting immunosurveillance ...... tions for cancer immunotherapy
@nl
prefLabel
Revisiting immunosurveillance ...... tions for cancer immunotherapy
@ast
Revisiting immunosurveillance ...... tions for cancer immunotherapy
@en
Revisiting immunosurveillance ...... tions for cancer immunotherapy
@nl
P2860
P356
P1476
Revisiting immunosurveillance ...... tions for cancer immunotherapy
@en
P2093
Christine V Ichim
P2860
P2888
P356
10.1186/1479-5876-3-8
P577
2005-02-08T00:00:00Z
P5875
P6179
1043178394